Obesity is a complex, multifactorial disease that develops from the interaction between genotype and environment. Our understanding of how and why obesity occurs is incomplete, however involves the integration of social, behavioral, cultural, metabolic, dietary and genetic factors. Obesity leads to other diseases such as hypertension, diabetes, and hyperlipidemia. The total cost of obesity in the United States is estimated at $99.2 billion.
Under physician guidance, our line of Very Low Calorie Protein supplements have proven success in diet controlled weight loss. Our program has been implemented in well renowned Obesity Centers across the country, most notably at St-Lukes Roosevelt/Columbia, Brigham and Women's Hospital/Harvard, Beth-Israel Deaconess/Harvard, George Washington University Hospital, and Winthrop Hospital Center/NYU. The hallmark for our success is patient compliance. Our variety of flavors and textures, keeps patients engaged in their road to success.
The products have a long history of safety, efficacy and consumer liking. The original program was developed in collaboration with St. Luke's Roosevelt Hospital in New York, under the guidance of Dr. Theodore VanItalle, MD, PhD with NutraLab. There are over 100 studies that support the formulation. Most notable study conducted by Dr. A.N. Vaswani, showed significant retention of weight loss 18 months after completion of the program.